Watch Ticker

Lisata Therapeutics, Inc. Common Stock

Go to Lisata Therapeutics, Inc. Common Stock Website

$2.60

-0.20 (-7.14%)

Live

Previous Close

$2.6

Day Range

$2.5547 - $2.7809

Previous Day Range

$2.78 - $3.026

Market Cap

$25.5 million USD

Day Vol.

26099

Previous Day Vol.

73531

Currency

USD

Primary Exchange

Nasdaq

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Lisata Therapeutics - Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update

Lisata Therapeutics and WARPNINE completed patient enrollment in a Phase 1b/2a trial evaluating certepetide for locally advanced pancreatic cancer, reporting promising preliminary data with a 60% overall response rate and 100% disease control rate.

Related tickers: LSTA, AZN.

Read Full Article

N/A - Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research

Lisata Therapeutics' lead pipeline candidate, certepetide, has shown promising results in a preclinical study for treating intrahepatic cholangiocarcinoma, an aggressive form of cancer. The positive data underlines the potential of certepetide in improving the tumor environment and making tumors more responsive to immunotherapy.

Related tickers: LSTA, ANIP, ADPT, RAPT.

Read Full Article

Trending Tickers

Please sign in to view